Patients treated with natural (leukocyte-derived) interferon (IFN)-alpha do not develop IFN antibodies.
Osterborg
A
A
Engman
K
K
Björeman
M
M
Carlson
K
K
Kimby
E
E
Ohrling
M
M
Samuelsson
J
J
Osby
E
E
Mellstedt
H
H
D000906:Antibodies / Q000032:analysis; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000276:immunology / Q000628:therapy*; D011994:Recombinant Proteins
D000906:Antibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins